SCHEMBL20122522

SCHEMBL20122522

COC(=O)[C@H](CSC(=O)OCOC(=O)C(C)(C)C)NC(=O)C(C)(C)SC(=O)OCOC(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122523 0.90 CYP1A2 (0.37) —
SCHEMBL20122521 0.90 CYP1A2 (0.32) —
SCHEMBL20122448 0.90 — —
SCHEMBL20122519 0.89 — —
SCHEMBL20122557 0.89 — —
SCHEMBL20122397 0.89 — —
SCHEMBL20122590 0.88 — —
SCHEMBL20122545 0.88 CYP1A2 (0.31) —
SCHEMBL20122580 0.84 NPC1 (0.31) —
SCHEMBL20122578 0.84 ATM (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback